作者：
Alexi A,Wright [1]
;
Kari,Bohlke [2]
;
Deborah K,Armstrong [3]
;
Michael A,Bookman [4]
;
William A,Cliby [5]
;
Robert L,Coleman [6]
;
Don S,Dizon [7]
;
Joseph J,Kash [8]
;
Larissa A,Meyer [9]
;
Kathleen N,Moore [10]
;
Alexander B,Olawaiye [11]
;
Jessica,Oldham [12]
;
Ritu,Salani [13]
;
Dee,Sparacio [14]
;
William P,Tew [15]
;
Ignace,Vergote [16]
;
Mitchell I,Edelson [17]
作者单位：
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
[1]
American Society of Clinical Oncology, Alexandria, VA, United States.
[2]
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.
[3]
US Oncology Research and Arizona Oncology, Tucson, AZ, United States.
[4]
Mayo Clinic, Rochester, MN, United States.
[5]
University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States.
[6]
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States.
[7]
Edward Cancer Center, Naperville, IL, United States.
[8]
The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
[9]
Stephenson Oklahoma Cancer Center at the University of Oklahoma, Oklahoma City, OK, United States.
[10]
University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
[11]
Society of Gynecologic Oncology, Chicago, IL, United States.
[12]
The Ohio State University, Columbus, OH, United States.
[13]
Hightstown, New Jersey, United States.
[14]
Memorial Sloan Kettering Cancer Center, New York, NY, United States.
[15]
Leuven Cancer Institute, Leuven, European Union, Belgium.
[16]
Hanjani Institute for Gynecologic Oncology, Abington Hospital, Jefferson Health, Abington, PA, United States. Electronic address: Mitchell.Edelson@jefferson.edu.
[17]
DOI
10.1016/j.ygyno.2016.05.022
PMID
27650684
发布时间
2024-05-29
换一批
换一批
